NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions

Mild Cognitive Impairment

Interventions

DRUG

DAOIB

DRUG

Placebo

Trial Locations (1)

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER

NCT02239003 - NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter